CDK8/19 Rekombinanter Antikörper
CDK8/19 Rekombinant Antikörper für WB, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
250832D1
Kat-Nr. : 86276-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
86276-1-PBS bindet in WB, Indirect ELISA CDK8/19 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | CDK8/19 fusion protein Ag4731 |
| Vollständiger Name | cell division cycle 2-like 6 (CDK8-like) |
| Berechnetes Molekulargewicht | 502 aa, 57 kDa |
| Beobachtetes Molekulargewicht | 57 kDa |
| GenBank-Zugangsnummer | BC037289 |
| Gene symbol | CDK19 |
| Gene ID (NCBI) | 23097 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-A-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
The CDK8 homolog, CDK19 (Cdk11, CDC2L6) was discovered by Hidden Markov model (HMM) profiling of a eukaryotic protein kinase domain, and found to have approximately 91% sequence homology to Cdk8. The two proteins share a particularly high degree of sequence conservation in their kinase and cyclin binding domain (PMID: 30693281, 26985305). CDK8 and CDK19, collectively termed 'Mediator Kinase,' are incorporated, in a mutually exclusive manner, as part of a 4-protein complex called the Mediator kinase module. CDK8/19 inhibition suppressed the induction of NFκB-driven transcription by p21 (PMID: 28855340).



